Fatal outcome after heart transplantation caused by Aspergillus lentulus

Transplant Infectious Disease

Volumn 14, Issue 5, 2012, Pages

  Zbinden, A ^a   Imhof, A ^b   Wilhelm, M J ^c   Ruschitzka, F ^c   Wild, P ^c   Bloemberg, G V ^a   Mueller, N J ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Hospital of Langenthal   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Aspergillus lentulus; Heart transplantation; Invasive aspergillosis

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CYCLOSPORIN; ITRACONAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY; VORICONAZOLE;

ACCURACY; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS LENTULUS; CASE REPORT; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FATALITY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HALLUCINATION; HEART TRANSPLANTATION; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPERGILLOSIS; MALE; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SYSTEMIC MYCOSIS;

AGED; ANTIFUNGAL AGENTS; ASPERGILLUS; FATAL OUTCOME; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INVASIVE PULMONARY ASPERGILLOSIS; MALE; OPPORTUNISTIC INFECTIONS;

EID: 84867599317     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00779.x     Document Type: Article

References (17)

1. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18 (1): 44-69.
2. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001; 33 (11): 1824-1833.
3. Walsh TJ, Groll AH. Overview: non-fumigatus species of Aspergillus: perspectives on emerging pathogens in immunocompromised hosts. Curr Opin Investig Drugs 2001; 2 (10): 1366-1367.
4. Balajee SA, Kano R, Baddley JW, et al. Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network. J Clin Microbiol 2009; 47 (10): 3138-3141.
5. Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification. Antimicrob Agents Chemother 2008; 52 (4): 1244-1251.
6. Balajee SA, Nickle D, Varga J, Marr KA. Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping. Eukaryot Cell 2006; 5 (10): 1705-1712.
7. Balajee SA, Gribskov JL, Hanley E, Nickle D, Marr KA. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 2005; 4 (3): 625-632.
8. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/invasive Fungal Infections Cooperative Group and the National Institute Of Allergy And Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis 2008; 46 (12): 1813-1821.
9. CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi: Approved Standard M38-A2. Vol. 28, No. 16, Wayne, Pennsylvania: Clinical and Laboratory Standards Institute, 2008.
10. Balajee SA, Weaver M, Imhof A, Gribskov J, Marr KA. Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals. Antimicrob Agents Chemother 2004; 48 (4): 1197-1203.
11. Alhambra A, Catalan M, Moragues MD, et al. Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease. Rev Iberoam Micol 2008; 25 (4): 246-249.
12. Montenegro G, Sanchez Puch S, Jewtuchowicz VM, et al. Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis. J Med Microbiol 2009; 58 (Pt 3): 391-395.
13. Symoens F, Haase G, Pihet M, et al. Unusual Aspergillus species in patients with cystic fibrosis. Med Mycol 2010; 48 (Suppl 1): S10-S16.
14. Mortensen KL, Johansen HK, Fuursted K, et al. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. Eur J Clin Microbiol Infect Dis 2011; 30 (11): 1355-1363.
15. Yaguchi T, Horie Y, Tanaka R, Matsuzawa T, Ito J, Nishimura K. Molecular phylogenetics of multiple genes on Aspergillus section Fumigati isolated from clinical specimens in Japan. Nippon Ishinkin Gakkai Zasshi 2007; 48 (1): 37-46.
16. Staab JF, Kahn JN, Marr KA. Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent. Antimicrob Agents Chemother 2010; 54 (12): 4992-4998.
17. Mellado E, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Role of Aspergillus lentulus 14-alpha sterol demethylase (Cyp51A) in azole drug susceptibility. Antimicrob Agents Chemother 2011; 55 (12): 5459-5468.